• Immune Checkpoint Inhibitors in Cancer (Paperback / softback) 9780323549486
1 1
£62.85 GBP
£73.99 GBP £62.85 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

Immune Checkpoint Inhibitors in Cancer

Stay up to date with the fast-changing field of cancer checkpoint inhibitors

Fumito Ito (Edited by), Marc Ernstoff (Edited by)

9780323549486, Elsevier Health Sciences

Paperback / softback, published 28 August 2018

270 pages, 25 illustrations (25 in full color)
23.4 x 19 x 1.8 cm, 0.68 kg

"Overall, this is an informative and authoritative book that includes experiences from clinicians and scientists working at some of the most renowned cancer centers in the world."

-Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 100-5 Stars!

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.

  • Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages.

  • Helps you translate current research and literature into practical information for daily practice.

  • Presents information logically organized by disease site.

  • Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks.
  • Consolidates today’s available information on this timely topic into one convenient resource.

1. Tumor Immunology

2. Melanoma and Other Skin Cancers

3. Thoracic Malignancies

4. Gastrointestinal, Hepatobiliary, and Pancreatic Malignancies

5. Cancers of the Head and Neck

6. Urologic Malignancies

7. Gynecologic Malignancies

8. Breast Cancer

9. Hematologic Malignancies

10. Pediatric Malignancies

11. Toxicities Associated with Immune Checkpoint Inhibitors

12. Future of Immune Checkpoint Inhibitors

Subject Areas: Oncology [MJCL]
View full details